News
- Leukemia (AML): Bristol-Myers Squibb Onureg was approved by EU
- Diet can change intestinal and breast flora and affects breast cancer risk
- WHO: Delta variant will become the world main popular variant virus strain
- Clinical application of interleukin in tumor immunotherapy
- Red meats: DNA damage and colorectal cancer-related gene mutations
- Why reversing intravenous thrombolysis after DOAC is not recommended?
Contact us
Please send email to info@medicaltrend.org or complete the below form. Thanks!
Please click "Send" after completing.
Gutentor Simple Text
Gutentor Simple Text
New drug for Leukemia(AML): Bristol-Myers Squibb Onureg (Azacitidine Tablets) was approved by EU
Le…
Read More
Studies have found that Diet can change intestinal and breast flora and affects breast cancer risk
…
Read More
WHO: Delta variant will become the world main popular variant virus strain
WHO: Delta variant wi…
Read More
Clinical application of interleukin in tumor immunotherapy
Clinical application of interleukin i…
Read More
Red meats: DNA damage and colorectal cancer-related gene mutations
Red meats: DNA damage and colore…
Read More
Why reversing intravenous thrombolysis after DOAC is not recommended by European Thrombolysis Guidel…
Read More
